This inventor holds 5 USPTO granted patents and 2 published patent applications. Top assignees: Cisco Technology, Inc., Liangdan Sun, Other. Active years: 2019-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 21,399 
1 out of 1 
1 out of 834,570 Years Active: 2019-2025
Title: Innovations of Weiwei Chen in Protein Inhibitory Medicines
Introduction
Weiwei Chen is an accomplished inventor based in Hefei, China. He has made significant contributions to the field of protein inhibitory medicines, holding a total of 5 patents. His work focuses on developing compounds that target specific protein activities, offering advancements over traditional immunomodulators.
Latest Patents
Weiwei Chen's latest patents include innovative uses of compounds in inhibiting specific protein activities. One notable patent is for the use of a compound or medicinal derivative in inhibiting AIM2 protein activity. This compound demonstrates a strong targeting effect, providing a more accurate, rapid, effective, safe, and stable solution compared to traditional broad-spectrum immunomodulators. The compound exhibits a strong binding force with both human and mouse AIM2 proteins, with binding constants as high as K=1.56EM and K=5.12EM, respectively.
Another significant patent involves the use of a compound or pharmaceutical derivative in inhibiting CaMK2G protein activity. Similar to his AIM2 patent, this compound shows a strong targeting effect and offers advantages such as easy storage, stable activity, small molecular weight, lower production cost, and easy absorption. The binding constants for this compound with human-derived and mouse-derived CaMK2γ proteins are KD=2.54×10M and KD=6.84×10M, respectively.
Career Highlights
Weiwei Chen has worked with notable companies, including Cisco Technology, Inc. and Liangdan Sun. His experience in these organizations has contributed to his expertise in the field of protein inhibitors.
Collaborations
Some of Weiwei Chen's coworkers include Yasi Xi and Zhaoyi Jin, who have collaborated with him on various projects.
Conclusion
Weiwei Chen's innovative work in the field of protein inhibitory medicines showcases his dedication to advancing medical science. His patents reflect a commitment to developing targeted therapies that improve upon traditional methods.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile